The serine-threonine protein kinase inhibitor H-7 and the fungal metabolite cytochalasin B (CB) disrupt the actin microfilament network by different mechanisms, and increase outflow facility similarly in live monkeys. Their combined effect has therefore determined on total outflow facility in cynomolgus monkeys by 2-level constant pressure perfusion. (1) After unilateral anterior chamber (AC) bolus injection of H-7 [10 µ, 100 µ (subthreshold for increasing facility when given alone) or 500 µ (just-threshold)] followed by bilateral AC bolus injection of CB [2 µg (strong but submaximal for increasing facility when given alone)], no significant difference between eyes was observed. (2) After bilateral AC exchange with a subthreshold dose of H-7 (10 µ) followed by unilateral AC bolus injection of a subthreshold dose of CB (0n02, 0n05, 0n1 or 0n5 µg), 10 µ H-7 plus 0n1 or 0n5 µg CB increased facility by " 40 or 80 % compared to 10 µ H-7 alone. (3) After bilateral AC exchange with a maximal dose of H-7 (300 µ), followed by unilateral AC bolus injection of a subthreshold dose of CB (0n1 or 0n5 µg), 300 µ H-7 plus 0n5 µg CB increased outflow facility by 47 % compared to 300 µ H-7 alone. (4) After unilateral AC exchange with a maximal dose of H-7 (300 µ) followed by bilateral AC bolus injection of a nearmaximal dose of CB (2 µg), 300 µ H-7 plus 2 µg CB increased the facility by 67 % compared to 2 µg CB alone. The significant effect of combined subthreshold doses of H-7 and CB on outflow facility, the potentiation of the facility-increasing effect of a maximal H-7 dose by both subthreshold and nearmaximal CB doses, and the known cytoskeletal effects of both compounds, may suggest that both increase facility by disrupting actin filaments in the trabecular meshwork.
Introduction
Cytochalasin B (CB), a fungal metabolite, disrupts actin microfilaments by a complex mechanism which includes capping the filaments and preventing their elongation, thereby affecting a wide variety of actindependent cellular events including cell morphogenesis, motility and endocytosis (Davies and Allison, 1978 ; Godman and Miranda, 1978 ; Brenner and Korn, 1979 ; Brown and Spudich, 1981) . Initially, however, CB can induce intense cellular contraction . In monolayer cultures of human trabecular meshwork (HTM) cells, CB caused the cells to separate (Polansky et al., 1984) . In monolayer cultures of HTM cells grown on filters, CB induced a dramatic dose-related increase in hydraulic conductivity, accompanied by retraction of the cells and widening of the intercellular spaces (Perkins et al., 1988) . In living monkeys, CB Kaufman, Bill and Ba! ra! ny, 1977 ; Svedbergh et al., 1978 ; Kaufman and Erickson, 1982 ; Kaufman, 1987) dramatically increased outflow facility.
H-7 (1-(5-isoquinolinyl-sulfonyl)-2-methylpiperazine), a wide-range protein kinase inhibitor, blocks the phosphorylation activity of diverse serine-threonine kinases including protein kinase C, myosin light chain kinase (MLCK) and rho kinase (Hidaka et al., 1984 ; Chrzanowska-Wodnicka and Burridge, 1996) . Addition of H-7 to cultured cells inhibits acto-myosin contractility, leading to deterioration of the actin microfilament system and perturbation of its membrane anchorage. This, in turn, weakens cell-extracellular matrix focal contacts (more so than cell-cell adherens junctions) in Swiss 3T3 cells, PTK2 cells, chick lens epithelial cells and fibroblasts, porcine or bovine aortic endothelial cells, and HTM cells (Birrell et al., 1989 ; Yu and Gotlieb, 1992 ; Volberg et al., 1994 ; Epstein, Skinner and Roberts, 1997 ; Liu et al., 1998 ; Tian et al., 1998 ). In living monkeys, H-7 increased outflow facility to a similar degree as CB (Tian et al., 1998) .
In previous studies in cultured MDCK cells (Citi, 1992 ; Citi et al., 1994) . H-7 prevented the fall in transepithelial electrical resistance induced by cyto-0014-4835\99\060649j07 $30.00\0
# 1999 Academic Press chalasin D (CD, a cytochalasin with effects on actin filaments similar to those of CB) (Brenner and Korn, 1979) or calcium chelators. Since the fall in electrical resistance caused by calcium removal is due to an increase in the permeability of the paracellular ' shunt ' pathway (Martinez-Palomo et al., 1980) , the inhibitory effect of H-7 is believed to result from inhibiting dissociation of cellular junctions by interfering with contractility of the adherens junctionassociated microfilaments following treatment with calcium chelators or CD (Citi, 1992 ; Janson, Kolega and Taylor, 1991 ; Kolega, Janson and Taylor, 1991 ; Citi et al., 1994) . Those data suggested that although both CB and H-7 could interfere with the same cytoskeletal components, the cellular consequences of their effect on the actin system are quite different. In cultured cells CB and CD induce rapid and often quite vigorous cell contractions by decreasing the gel structure (solation) in the cellular contractile system Kolega, Janson and Taylor, 1991) , which, in conjunction with weakening of the adherens junctions consequent to microfilament disruption, leads to cell-cell separation. H-7 induces relaxation by inhibiting acto-myosin contractility, which stabilizes adherens junctions against disruption by CD-induced contraction , but weakens focal contacts by disrupting actin stress fibers . We considered that the application of both drugs at subthreshold levels might increase outflow facility without causing adverse effects on other anterior segment tissues, and thereby provide insights into developing a novel effective and safe treatment strategy for glaucoma. We therefore studied the combined effects of H-7 and CB on outflow facility in living monkeys.
Materials and Methods

Animals and Anesthesia
Normal cynomolgus monkeys (Macaca fascicularis), weighing 2n5-5n2 kg, were studied. All investigations were in accordance with University of Wisconsin and NIH guidelines, and with the ARVO Statement on the Use of Animals in Ophthalmic and Vision Research. Anesthesia for anterior chamber (AC) perfusion was induced by intramuscular (i.m.) ketamine (10 mg kg −" ), followed by i.v. pentobarbital-Na (15 mg kg −" ) or i.m. pentobarbital-Na (35 mg kg −" ).
Drugs and Chemicals
H-7 and CB were obtained from Sigma Chemical Co. (St. Louis, MO, U.S.A.), and DMSO (dimethyl sulfoxide) from Sigma or Research Industries Corporation (Salt Lake City, UT, U.S.A.). H-7 (0n1-5 m for bolus AC injection or 10 and 300 µ for AC exchange infusion) solutions were freshly prepared in Ba! ra! ny's mock aqueous humor (Ba! ra! ny, 1964). For CB, a 0n5 % stock solution in DMSO was stored at k20mC, and diluted with Ba! ra! ny's solution immediately before administration to provide 0n02, 0n05, 0n1, 0n5 or 2n0 µg of CB in 10 µl of 20 % DMSO for bolus AC injection. CB bolus doses 0n5 µg are subthreshold, and the 2n0 µg CB dose is strong but submaximal, when given alone (Kaufman and Erickson, 1982) . The 10 µ and 300 µ H-7 AC exchange doses are subthreshold and maximal respectively (Tian et al., 1998junpublished data) . H-7 bolus AC injection doses (10 µl of 0n1, 1 and 5 m), which produce 10, 100 and 500 µ initial AC concentration in the " 100 µl cynomolgus AC (Erickson et al., 1984) , are sub-threshold (10 and 100 µ) or just-threshold (500 µ), respectively, for increasing facility (Tian et al., 1998 ; Tian and Kaufman, unpublished data, 1997) .
Outflow Facility Measurement
Total outflow facility was determined by 2-level constant pressure perfusion of the AC with Ba! ra! ny's solution (Ba! ra! ny, 1964), correcting for internal apparatus resistance (Ba! ra! ny, 1965). The eyes were cannulated with a branched needle, with one branch connected to the pressure transducer and the other branch to a reservoir inflow line. For AC exchange the eyes were cannulated with an additional single needle connected to an infusion pump. During the exchange, the tubing between the reservoir and the branched needle was disconnected temporarily and used as an outflow line while maintaining the intraocular pressure at " 10 mmHg. Most monkeys had undergone more than one prior perfusion but none within the preceding 5-6 weeks ; all were free of anterior chamber cells and flare by biomicroscopy. Baseline facility was determined bilaterally for 35 min in all perfusion experiments.
Unilateral H-7 bolusjbilateral CB bolus Following baseline facility measurement, 10 µl of 0n1, 1 or 5 m H-7 was injected via a t-piece into the inflow tubing of one eye [10, 100 or 500 µ in the " 100 µl anterior chamber (Erickson et al., 1984) ], vehicle (Ba! ra! ny's solution) to the opposite eye. Five minutes were allowed for the drug to wash into the AC, followed by 3 min of convection mixing of the AC contents by cold air blown on the cornea. The reservoirs were then closed for 30 min, after which 2n0 µg CB in 10 µl was administered into the inflow tubing (reservoirs open) of both eyes, 8 min allowed for wash-in and convection mixing, and the reservoirs were closed again for 15 min. The reservoirs were then opened and post-drug facility determined for 45 min.
Bilateral H-7 exchangejunilateral CB bolus Following baseline facility measurement, the ACs were exchanged bilaterally (2 ml for 10 min) with 10 or 300 µ H-7 solution, and the reservoirs filled with the corresponding exchange solutions. The reservoirs were closed for 30 min. Ten microliters of CB (0n02, 0n05, 0n1 or 0n5 µg) or vehicle (20 % DMSO, which T I Facility data are meanp... (µl min−" mmHg−") for n animals, each contributing one treated eye receiving H-7jCB and one control eye receiving CB or H-7 alone ; ratios are unitless. * P 0n054, † P 0n05, ‡ P 0n01 for ratios different from 1n0 by the 2-tailed paired t test.
H-7 and CB combined effects on outflow facility
F. 1. Effect of bilateral intracameral exchange (Ex) of a subthreshold dose of H-7 (10 µ) followed by unilateral bolus (Bo) injection of subthreshold doses of CB (A : 0n1 µg; B: 0n5 µg) on outflow facility. Reservoir (Res) was filled with the corresponding H-7 solution after intracameral Ex. BL, baseline. Data are meanp... µl min −" mmHg −" for n monkeys, each contributing 1 eye receiving H-7 and 1 eye receiving H-7 and CB.
produces a 2 % initial DMSO concentration in the 100 µl cynomolgus AC) was then injected into the inflow tubing of opposite eyes with the reservoirs open. Wash-in and convection mixing were as above. The reservoirs were then re-closed for 15 min after CB administration and reopened for 45 min of post-drug facility measurement.
Unilateral H-7 exchangejbilateral CB bolus Baseline facility measurement was followed by AC exchange with one eye receiving 300 µ H-7 and the other receiving vehicle (Ba! ra! ny's solution). The reservoirs were then filled with the corresponding exchange solutions and closed for 30 min. The reservoirs were then opened and 2n0 µg CB was injected via t-pieces to both eyes, followed by wash in and convection mixing, as above. The reservoirs were re-closed for 15 min, then opened and facility was determined for 45 min.
Data Analysis
Data are presented as meanp... for n eyes or animals. Pre-or post-drug treated vs. contralateral control ; post-drug or post-vehicle vs. ipsilateral baseline ; and baseline corrected post-drug treated vs. control comparisons were made using the 2-tailed paired t test for ratios vs. 1n0. For example, a treated\control ratio of 1n25p0n10 indicates that the treated value exceeds the control value by 25 %, with an SEM of 10 %. The ratio 1n25p0n10 is tested against 1n00p0n00 (a ratio of 1n0 representing no change) to determine if the apparent increase is statistically significant.
Results
Unilateral H-7 BolusjBilateral CB Bolus
In the present study, bolus intracameral injection of 2n0 µg CB more than doubled facility, far in excess of the 15 % or 0n5% min −" increase typically induced by perfusion with vehicle alone (perfusion induced resistance-washout ; Kaufman and Ba! ra! ny, 1977 ; Svedbergh et al., 1978 ; Erickson and Kaufman, 1981 ; Kaufman and Erickson, 1982 ; Kaufman, True-Gabelt and Erickson, 1988 ; [ Table I (A)-(C)]. The facility increase was of similar magnitude in the contralateral eyes receiving bolus injection of 10-500 µ H-7 prior to 2n0 µg CB [Table I(A)-(C)].
Bilateral H-7 ExchangejUnilateral CB Bolus
Similar to previous data (Tian et al., 1998) , AC exchange with 10 µ H-7 alone [Table I(F), (G)] had no effect on facility but subsequent bolus injection of 0n1 µg or 0n5 µg CB increased the facility by 82p24 % (P 0n02) or 43p9% (P 0n005), relative to baseline and adjusted for washout occurring in the 10 µ H-7-only treated eyes [ Fig. 1(A) , (B), Table I(F), (G)]. 10 µ H-7j0n02 or 0n05 µg CB produced insignificant 18 % and 15 % facility increases respectively [P 0n05, Table I(D), (E)]. AC exchange with 300 µ H-7 alone doubled facility relative to ipsilateral baseline [118 % or 109 %, Table I(H), (I)]. However, 300 µ H-7 AC exchangej0n1 or 0n5 µg CB bolus increased facility by 152 % or 206 % compared to ipsilateral baseline. When compared to 300 µ H-7-only treated eyes, the CB induced facility increase F. 2. Effect of bilateral intracameral exchange (Ex) with a maximal dose of H-7 (300 µ) followed by unilateral bolus (Bo) injection of subthreshold doses of CB [(A) 0n1 µg ; (B) 0n5 µg], or unilateral Ex with a maximal dose of H-7 followed by bilateral Bo injection of a near-maximal dose of CB (C : 2n0 µg) on outflow facility. Reservoir (Res) was filled with corresponding H-7 or vehicle solution after intracameral Ex. BL, baseline. Data are meanp... µl min −" mmHg −" for n monkeys, each contributing 1 eye receiving one drug and 1 eye receiving both drugs.
proportional to baseline was another 20p13 % (NS) or 47p16 % (P 0n05) higher, respectively [ Fig. 2 
(A), (B) ; Table I(H), (I)].
Unilateral H-7 ExchangejBilateral CB Bolus
Bolus intracameral injection of 2n0 µg CB alone or AC exchange with 300 µ H-7 alone each increased facility " 2-fold compared to ipsilateral baseline [136 % for 2n0 µg CB, Table I(J) ; 118 % or 109 % for 300 µ H-7, Table I(H), (I)]. However, AC exchange with 300 µ H-7jbolus intracameral injection of 2n0 µg CB increased facility up to " 3-fold compared to ipsilateral baseline (285 %, Table I(J)] . When compared to the 2n0 µg CB-only treated eyes, facility in the H-7jCB-treated eyes was increased an additional 67p14 % (P 0n005), proportional to baseline [ Fig. 2(C) ; Table I(J)] . When compared to the 300 µ H-7-only treated eyes [ Table I (H) or (I)], facility in the H-7jCB-treated eyes [Table I(J)] was increased an additional 77 % (P 0n05) or 84 % (P 0n025 ; 2-sample unpaired t test).
Discussion
Longer-term exposure to DMSO concentrations in the range we used might damage cells in culture (Layman, 1987 ; Crawford and Braunwald, 1991 ; Rinkes et al., 1992) , and DMSO has been reported to induce formation of actin filament networks in cultured rat hepatocytes (Kojima et al., 1997) and the formation of microtubules in cultured arterial smooth muscle cells (Katsuda, Okada and Nakanishi, 1987) . However, the situation may be quite different in the living eye under our relatively brief perfusion conditions. The actual concentration ' seen ' by the TM cells in vivo may be less than that administered into the central AC, the cells may have ' coatings ' or other ' defense ' mechanisms not available in a cell culture environment, the duration of exposure may be too short to induce major functional or structural changes, etc. In the living perfused monkey eye, [DMSO] AC 4 % decreased outflow facility, while lower concentrations had no effect on the facility (Kiland et al., 1997) . In the present study, the initial [DMSO] AC following CB bolus injection was only 2 %, and declined thereafter. Moreover, we used 2 % DMSO in both eyes, so our comparisons were always to a contralateral control receiving the same vehicle.
In the present study, the initial intracameral concentrations of 10-500 µ H-7 presumably achieved after bolus injection did not alter the outflow facility response to 2n0 µg CB. Bolus injection to achieve initial intracameral concentrations of 10 or 100 µ H-7 alone is ineffective, but 500 µ H-7 alone is a threshold dose for increasing facility (Tian and Kaufman, unpublished data, 1997) , as is AC exchange with 100 µ H-7 (Tian et al., 1998) . The dose ratio of " 5 : 1 between bolus and exchange infusion holds also for pilocarpine hydrochloride (Gabelt, Crawford and Kaufman, 1991 ; Gabelt and Kaufman, 1992) , and may be consequent to incomplete mixing and rapidly decreasing AC drug concentration following bolus injection. Therefore, the lack of synergy in the H7jCB bolus combinations may be due to : (1) insufficient H-7 concentration and\or time in the AC ; (2) a facility response near to the system's physiological maximum produced by 2n0 µg CB itself (see below) ; and (3) the difference between responses to 2n0 µg CB and 2n0 µg CBj10, 100 or 500 µ H-7 being too small for resolution by the perfusion technique.
To clarify these uncertainties we then used protocols in which H-7 was administered by AC exchange while CB doses were given by bolus AC injection. We found that : (a) combining subthreshold doses of CB and H-7 produced significant facility increases beyond perfusion-induced resistance washout ; (b) combining subthreshold doses of CB and a maximal dose of H-7 produced facility increases significantly higher than those produced by H-7 alone ; and (c) combining a near-maximal dose CB and a maximal dose of H-7 produced a facility increase of greater magnitude than either alone. Findings (a) and (b) could indicate that the pathways by which H-7 and CB increase outflow facility converge at some point presumably involving deterioration of actin microfilaments in TM\ Schlemm's canal cells (Robinson and Kaufman, 1991 ; Robinson and Kaufman, 1994) , with consequent alterations of cell-cell and\or cell-extracellular matrix adhesions. Finding (c) also could be consistent with this interpretation, but alternatively could suggest that H-7 and CB may increase facility at least in part by different mechanisms.
In a previous study, combined treatment with maximal facility-effective doses of CB and epinephrine did not increase facility by more than the " 150 % induced by CB alone (Robinson and Kaufman, 1991) . Therefore, it was hypothesized that once cell shape had changed to the extent produced by the large CB dose, further shape changes are not possible or have no additional consequences for facility. However, in the present study, the facility-increasing effect of a maximal dose of H-7 was potentiated dose-dependently by subthreshold and near-maximal CB doses. Furthermore, when compared to ipsilateral predrug facility, facility in the eyes receiving 300 µ H-7 plus either subthreshold (0n1 or 0n5 µg) or near-maximal (2n0 µg) doses of CB was increased by 152 %, 206 % or 285 % [" 130 %, " 180 % or 260 %, adjusted for the 0n5%\min ' washout ' seen in other comparably-timed perfusions without drugs (Erickson and Kaufman, 1981 ; Kaufman and Erickson, 1982) ], equivalent or considerably more than the facility increase (" 150 %) induced by a maximally effective dose of either CB [5n0 µg Kaufman and Erickson, 1982) ] or H-7 [300 µ (Tian et al., 1998)] alone. These findings could be due to CB-induced cellular contractions perturbing cell-cell adhesion , complimenting H-7's predominant effects on cell-extracellular matrix adhesion (Tian et al., 1998) .
Preliminary ultrastructural studies indicate that administration of H-7 into monkey eyes has rather mild effects on cell-cell adhesion, but induces a generalized relaxation and apparent expansion of the TM and Schlemm's canal (Gabelt et al., 1999) . Following AC exchange infusion of H-7 in living monkey eyes, the initial facility value was only slightly elevated, but continued drug-free perfusion produced substantial facility elevation even as the drug concentration declined (Tian et al., 1998) . This suggests that TM architecture may be only slightly affected by H-7, but that at higher-pressure gradients\flow rates (e.g. in perfusion), the slightly destabilized TM architecture is further disrupted sufficiently to substantially reduce flow resistance. Following perfusion with CB, the TM in monkey eyes was greatly distended and the cells in the juxtacanalicular region and the inner wall of Schlemm's canal were pulled apart (Svedbergh et al., 1978 ; Johnstone et al., 1980) . Therefore, both compounds increase facility during perfusion most likely by weakening cell adhesions, leading to loosening and distension of overall TM architecture. CB could contribute to the labilization of actinassociated structures, which are relatively insensitive to H-7 (i.e., cell-cell junctions), while the anticontractile effects of H-7 might moderate the disruption of tissue architecture induced by CB. Combined administration of carefully chosen small doses might reduce the actions of each agent on ocular tissues not subjected to trans-tissue flow, while preserving flowdependent facility effectiveness, which seems to require flow across the TM.
